Bank of New York Mellon Corp Sells 35,447 Shares of Dolby Laboratories $DLB

Bank of New York Mellon Corp trimmed its position in shares of Dolby Laboratories (NYSE:DLB) by 0.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,549,482 shares of the electronics maker’s stock after selling 35,447 shares during the period. Bank of New York Mellon Corp owned 5.79% of Dolby Laboratories worth $401,616,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. First Horizon Corp purchased a new position in shares of Dolby Laboratories during the 3rd quarter valued at $25,000. Allworth Financial LP raised its stake in Dolby Laboratories by 590.4% in the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock valued at $37,000 after acquiring an additional 431 shares during the period. Mather Group LLC. purchased a new stake in Dolby Laboratories during the third quarter valued at about $38,000. Ameritas Advisory Services LLC bought a new position in Dolby Laboratories during the second quarter worth about $48,000. Finally, Atlantic Union Bankshares Corp purchased a new position in shares of Dolby Laboratories in the second quarter worth about $50,000. 58.56% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Dolby Laboratories

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Q1 beat on top‑ and bottom‑line estimates — Dolby reported $1.06 EPS vs. a ~$0.90 consensus and revenue of $346.7M vs. ~$341M, showing the quarter topped Street forecasts. Read More.
• Positive Sentiment: Management tone constructive — CEO Kevin Yeaman described a “good start to the fiscal year” and expressed confidence in growth opportunities, which supports near‑term sentiment. Read More.
• Neutral Sentiment: Analyst coverage is mixed but skewed positive — several firms maintain buy/outperform ratings and price targets well above the current price (median target cited ~$87.50), giving upside narrative but not immediate catalyst certainty. Read More.
• Neutral Sentiment: Company provided investor materials and call recording/press release for follow‑up — useful for investors who want to verify guidance and metric details. Read More.
• Negative Sentiment: Profitability and cash‑flow weaker YoY — operating profit, net income and gross profit declined year‑over‑year and cash from operations was reported negative, highlighting margin pressure and near‑term cash concerns that could limit upside. Read More.
• Negative Sentiment: Insider selling and recent analyst downgrades/1‑year low headlines add downside risk — heavy insider sales and at least one noted downgrade contributed to recent negative attention. Read More.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DLB. Barrington Research dropped their price target on shares of Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating on the stock in a research note on Monday. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 29th. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Monday, January 5th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research note on Thursday, January 22nd. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and an average price target of $90.75.

Insider Activity at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 6,751 shares of the stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $67.24, for a total value of $453,937.24. Following the transaction, the chief executive officer owned 98,377 shares of the company’s stock, valued at $6,614,869.48. This represents a 6.42% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction on Friday, November 21st. The shares were sold at an average price of $65.55, for a total transaction of $196,650.00. Following the sale, the senior vice president owned 67,435 shares in the company, valued at approximately $4,420,364.25. This trade represents a 4.26% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 137,120 shares of company stock valued at $9,184,809. Company insiders own 37.93% of the company’s stock.

Dolby Laboratories Stock Performance

Dolby Laboratories stock opened at $62.89 on Friday. Dolby Laboratories has a fifty-two week low of $60.14 and a fifty-two week high of $89.66. The stock has a market cap of $6.01 billion, a P/E ratio of 23.91 and a beta of 0.88. The firm’s fifty day moving average price is $65.14 and its 200-day moving average price is $68.95.

Dolby Laboratories (NYSE:DLB) last posted its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, topping the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The business had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. During the same period in the previous year, the business earned $0.61 earnings per share. The firm’s revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Sell-side analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were paid a $0.36 dividend. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Tuesday, December 2nd. Dolby Laboratories’s payout ratio is 54.75%.

Dolby Laboratories Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.